Is KBBTF or RYLD a better dividend investment in 2026?

KBBTF currently yields 208.33% with a 5% 5-year dividend growth rate. RYLD yields 12.14% with 5% growth. The better choice depends on your goal: KBBTF offers higher current income.

What is the dividend yield difference between KBBTF and RYLD?

KBBTF has a forward dividend yield of 208.33% ($2.00/share annually). RYLD yields 12.14% ($1.81/share annually). The yield gap is 196.19 percentage points.

Home › Compare › KBBTF vs RYLD

KBBTF vs RYLD: Dividend Comparison 2026

KBBTF yields 208.33% · RYLD yields 12.14%● Live data

vsPost on X →

After 10 years · $10,000 invested · DRIP enabled

🏆 KBBTF wins by $151.44M in total portfolio value

INVESTMENT

TIME HORIZON10 years

KBBTF

● Live price

208.33%

Share price

$0.96

Annual div

$2.00

5Y div CAGR

Payout ratio

50%

After 10 yrs · $10,000 · DRIP

Portfolio value

$151.48M

Annual income

$77,914,744.95

Full KBBTF calculator →

RYLD

● Live price

12.14%

Share price

$14.95

Annual div

$1.81

5Y div CAGR

Payout ratio

50%

After 10 yrs · $10,000 · DRIP

Portfolio value

$44.5K

Annual income

$2,587.35

Full RYLD calculator →

Portfolio growth — KBBTF vs RYLD

📍 KBBTF pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis Period	KBBTF	RYLD
2008–2009 GFC	— No data	— No data
2020 Q1–Q2 COVID	— No data	— No data
2022 Q4 Rate Hike	— No data	— No data

Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.

📅

Dividend Calendar Overlap

Combined, KBBTF + RYLD cover 0 of 12 months — good coverage

Jan

—

Feb

—

Mar

—

Apr

—

May

—

Jun

—

Jul

—

Aug

—

Sep

—

Oct

—

Nov

—

Dec

—

KBBTF pays

RYLD pays

Both pay

Neither

💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

KBBTF

Annual income on $10K today (after 15% tax)

$17,708.33/yr

After 10yr DRIP, annual income (after tax)

$66,227,533.21/yr

RYLD

Annual income on $10K today (after 15% tax)

$1,031.60/yr

After 10yr DRIP, annual income (after tax)

$2,199.25/yr

At 15% tax rate, KBBTF beats the other by $66,225,333.96/year in after-tax income after 10 years on $10,000

⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of KBBTF + RYLD for your $10,000?

KBBTF: 50%RYLD: 50%

100% RYLD50/50100% KBBTF

Portfolio after 10yr

$75.76M

Annual income

$38,958,666.14/yr

Blended yield

51.42%

🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

KBBTF buys

RYLD buys

No recent congressional trades found for KBBTF or RYLD in the last 90 days.

STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →

MetricKBBTFRYLD

Forward yield	208.33% ✓	12.14%
Annual dividend / share	$2.00 ✓	$1.81
Payout ratio	50%	50%
1-year div growth	0%	0%
5-year div CAGR	0%	0%
Portfolio after 10y	$151.48M ✓	$44.5K
Annual income after 10y	$77,914,744.95 ✓	$2,587.35
Total dividends collected	$143.08M ✓	$18.8K
Payment frequency	quarterly	quarterly
Sector	Stock	ETF

Year-by-year: KBBTF vs RYLD ($10,000, DRIP)

Year	KBBTF Portfolio	KBBTF Income/yr	RYLD Portfolio	RYLD Income/yr	Gap
1← crossover	$31,533	$20,833.33	$11,914	$1,213.65	+$19.6K → KBBTF
2	$95,137	$61,396.68	$14,099	$1,351.30	+$81.0K → KBBTF
3	$274,915	$173,118.00	$16,580	$1,494.55	+$258.3K → KBBTF
4	$761,685	$467,526.04	$19,384	$1,642.61	+$742.3K → KBBTF
5	$2,025,599	$1,210,595.57	$22,535	$1,794.70	+$2.00M → KBBTF
6	$5,176,190	$3,008,799.54	$26,063	$1,950.00	+$5.15M → KBBTF
7	$12,724,177	$7,185,654.07	$29,995	$2,107.69	+$12.69M → KBBTF
8	$30,123,158	$16,508,287.86	$34,361	$2,266.99	+$30.09M → KBBTF
9	$68,756,679	$36,524,900.02	$39,194	$2,427.12	+$68.72M → KBBTF
10	$151,484,391	$77,914,744.95	$44,525	$2,587.35	+$151.44M → KBBTF

KBBTF vs RYLD: Complete Analysis 2026

KBBTF — Stock

Kubota Pharmaceutical Holdings Co., Ltd. develops portfolio of drugs and devices in the ophthalmic field worldwide. Its product pipeline comprises emixustat hydrochloride, which is in Phase III clinical stage used for the treatment of stargardt disease, and Phase II clinical stage used for the treatment of proliferative diabetic retinopathy. The company is also developing remote retinal monitoring device, a home-based and patient self-monitoring optical coherence tomography devices to treat wet age-related macular degeneration and diabetic macular edema, which brings retinal edema and reduction in visual acuity; and wearable device for myopia control. The company was founded in 2002 and is based in Tokyo, Japan.

Full KBBTF Calculator →

RYLD — ETF

The Global X Russell 2000 Covered Call ETF (RYLD) seeks to provide investment results that correspond generally to the price and yield performance, before fees and expenses, of the Cboe Russell 2000 BuyWrite Index.

Full RYLD Calculator →

📬

Get this KBBTF vs RYLD comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

KBBTF vs SCHD KBBTF vs JEPI KBBTF vs O KBBTF vs KO KBBTF vs MAIN

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.